Currently out of the existing stock ratings of Mike Polark, 78 are a BUY (64.46%), 22 are a HOLD (18.18%), 21 are a SELL (17.36%).

Mike Polark

Work Performance Price Targets & Ratings Chart

Analyst Mike Polark, currently employed at BAIRD, carries an average stock price target met ratio of 70.85% that have a potential upside of 14.34% achieved within 177 days. Previously, Mike Polark worked at WOLFE.

Mike Polark’s has documented 226 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSP, Inspire Medical Systems at 03-Nov-2026.

Wall Street Analyst Mike Polark

Analyst best performing recommendations are on TMO (THERMO FISHER SCIENTIFIC).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 9/1/2020. The price target of $220 was fulfilled within 2 days with a profit of $6.7 (2.96%) receiving and performance score of 14.78.

Average potential price target upside

HRC Hill-Rom Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Sep-2017

$156

$0.28 (0.18%)

$155

5 years 8 days ago
(05-Nov-2021)

5/6 (83.33%)

$1.18 (0.76%)

148

Buy Since 21-Sep-2020

$156

$0.28 (0.18%)

$125

5 years 1 months 25 days ago
(19-Sep-2021)

10/11 (90.91%)

$5.73 (3.81%)

256

Buy Since 02-Aug-2021

$156

$0.28 (0.18%)

$148

5 years 1 months 27 days ago
(17-Sep-2021)

1/2 (50%)

$5.73 (3.81%)

31

Buy Since 21-Jan-2016

$145

5 years 2 months 5 days ago
(08-Sep-2021)

6/6 (100%)

$6.96 (5.04%)

324

Buy Since 02-Sep-2020

$156

$0.28 (0.18%)

$150

5 years 2 months 10 days ago
(03-Sep-2021)

4/5 (80%)

$4.79 (3.17%)

107

Show more analysts

Please expand the browser size to see the chart

Which stock is Mike Polark most bullish on?

Potential upside of $20.07 has been obtained for ABT (ABBOTT LABORATORIES)

Which stock is Mike Polark most reserved on?

Potential downside of -$119.8 has been obtained for TMO (THERMO FISHER SCIENTIFIC)

What Year was the first public recommendation made by Mike Polark?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?